Information | |
---|---|
has gloss | eng: Semicarbazide-cadmium therapy was an experimental cancer therapy that was tested in several clinical trials in Russia during the 1960s. Semicarbazide is an irreversible inhibitor of semicarbazide-sensitive amine oxidase (SSAO), an enzyme possibly involved in exacerbation of inflammation. Cadmium is a toxic metal and can also induce apoptosis. |
lexicalization | eng: Semicarbazide-Cadmium Therapy |
instance of | c/Experimental medical treatments |
Lexvo © 2008-2025 Gerard de Melo. Contact Legal Information / Imprint